Domenico Recoli

Title: The Innovative Contributions of Domenico Recoli

Introduction

Domenico Recoli is a notable inventor based in Magog, Canada. He has made significant contributions to the field of medical science, particularly in the development of novel antagonists to the B-bradykinin (B-BK) receptor. His work addresses critical health issues associated with inflammation and diabetes.

Latest Patents

Domenico Recoli holds a patent related to antagonists of the B-BK receptor. This invention demonstrates good affinity and selectivity for the receptor, with some compounds being partially resistant to enzymatic degradation. The synthesis of B-receptors is induced during inflammation, and symptoms associated with this condition have been observed in diabetic animal models. His research confirms the presence of B-BK receptors in these models, and the antagonists developed have shown the ability to abolish vasocontraction induced by B-BK, as well as reduce glycemia in diabetic animals to normal levels. This patent is particularly useful for treating conditions where B-receptor expression results in diabetic vasculopathy and other related symptoms.

Career Highlights

Domenico Recoli is affiliated with the Université de Sherbrooke, where he continues to advance his research in the field of pharmacology and inflammation. His innovative work has the potential to impact the treatment of various diabetic conditions significantly.

Collaborations

Domenico has collaborated with notable colleagues such as Gerard E Plante and Adriana Zucollo. Their combined expertise enhances the research and development of effective treatments for inflammation-related conditions.

Conclusion

Domenico Recoli's contributions to the field of medical science through his innovative patents highlight the importance of research in addressing health challenges. His work not only advances scientific knowledge but also offers hope for improved treatments for patients suffering from diabetes and inflammation-related conditions.